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Alcoholism is one of the largest public health problems of the nation and is a significant 
cofactor in such ubiquitous diseases as hypertension, developmental abnormalities, heart 
failure, liver failure, and many other conditions. The cost to the nation’s health is immense. 
One strategy for reducing morbidity and cost has been to establish methods for screening in 
order to increase recognition rates leading to increased rates of therapeutic intervention. In 
this article, the rationale for two methods of alcohol screening, brief interviews and biolog- 
ical markers of excessive drinking, the relevant statistical issues bearing on this problem, 
and the current research on screening exams are reviewed and summarized. Finally, some 
of the newer approaches toward alcoholism screening as well as the consequences to the 
medical care system should alcohol screening eventuate on a large scale are briefly de- 
scribed. 0 1988 Academic PM, IN. 
RATIONALE 
There are several reasons to screen people for alcohol addiction. The most 
often cited is economic: an annual cost to the nation in excess of 50 billion dollars 
(25) through utilization of health facilities, lost time at work, injuries and acci- 
dents, use of the legal system, and so on. At the same time, news reports regularly 
record the human costs of alcoholism, for example the accidental deaths among 
our young people that have spawned organizations such as Mothers Against 
Drunk Driving (MADD). More recently, the public has become aware of medical 
conditions more closely linked to alcohol abuse than was previously thought: 
widespread hypertension (14), subtle developmental changes in children whose 
mothers drank alcohol during pregnancy (28) heart failure and premature death in 
men (8), and cirrhosis of the liver among women (19). All of these and other 
reasons, frequently appearing in scientific, professional, and popular media, have 
followed a national awakening that began with the establishment of the National 
Institute on Alcohol Abuse and Alcoholism 15 years ago. 
The fundamental justification for alcoholism screening lies in the presumed 
opportunity to prevent or ameliorate the economic, human, and medical costs 
noted above. The ultimate unproven hypothesis for those of us who work at 
devising and testing better screening methods for alcoholism is that by doing so 
we will offer the nation a method whereby it can substantially reduce the mor- 
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bidity, mortality, and economic drain currently ascribed to alcohol misuse. While 
some early data suggest that alcohol recognition reduces medical costs substan- 
tially when persons recognized as alcoholic reach treatment, the larger question 
awaits the development of screening instruments that can be used systematically 
for large numbers of the Americans along with adequate systems of diagnosis, 
treatment, and follow-up for this most difficult of diseases. Surely, in the great 
traditions of medicine whereby we seek to limit and assuage the suffering of 
others, devising accurate screening tests for an illness that affects 7-10% of the 
population over their lifetime remains a worthy, if less than glamorous, task. 
In considering this task, we must reflect on some of the attributes of alcoholism 
that both facilitate and impede screening processes. The greatest obstruction to 
screening has to do with the nature of the illness itself. Alcoholism is an addictive 
disease: it has four general characteristics shared with other addictions. A person 
suffering from alcoholism (including the synonomous terms “alcohol 
dependence,” and “alcohol addiction”) demonstrates symptoms pertaining to at 
least two of the four following major symptom categories. First, tolerance devel- 
ops such that the drinking person requires greater amounts of alcohol to achieve 
the same subjective effect once achieved with much less alcohol. Second, with- 
drawal symptoms occur some 6 to 12 hr after a rapid drop in serum alcohol level. 
These include tachycardia, hypertension, tachypnea, mild hyperpyrexia, tremor, 
nausea (with and without vomiting), diaphoresis, and anxiety. More severe cases 
include withdrawal seizures and delirium tremens. Third, the person experiences 
a fess of control when drinking alcohol. After drinking begins, it cannot be 
stopped or limited in any consistent fashion thereafter. And fourth, the drinking 
patient experiences a marked social decline in relationships with others whether 
in the family, at work, with friends, with religious organizations or with legal 
institutions. Most accepted diagnostic criteria for alcoholism include symptoms or 
signs from each of these four major categories (10, 26). 
Following Sir William Osler’s law of parsimony, all of the symptoms and related 
physical complications of alcoholism stem from the inability of the drinking per- 
son to control the intake of alcohol once it has begun. The nature of this inability, 
in its biological, psychological, or social aspects, is currently the subject of much 
investigation. The only aspect germane to the present discussion, however, is that 
the loss of control of drinking inevitably brings about feelings of guilt and shame 
which in turn cause the alcoholic person to hide or greatly minimize the problem. 
Coexisting with this guilt and shame, there is usually a subjective perception of 
benefit on the part of the alcoholic for a substance that in some way, either 
presently or in the past, provided some effect that the individual regarded as good. 
In the interest of denying or avoiding shame before others or guilt in one’s own 
mind, while simultaneously protecting a positive experience, alcoholism causes 
its victims to hide their illness from others. It is a disease designed to remain 
undiagnosed. 
In its early stages, before the onset of obvious physical sequelae, alcoholism 
mimics a number of other diseases and syndromes for which we have specific 
pharmacologic treatment and toward which the clinician is inevitably biased given 
the common lack of awareness about treatment for alcoholism. Two of the most 
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common examples are major depressive disease and anxiety disorder. Alcoholism 
mimics the former because of the depressant characteristics of the chemical itself 
as well as the withdrawal symptoms that mimic the “vegetative” or “biologic” 
signs of major depressive disease. Similarly, alcohol withdrawal easily mimics an 
anxiety disorder with respect both to the presenting symptoms and to the con- 
stancy of the symptoms in a person constantly drinking. In short, neither the 
alcoholic patient nor the clinician unaware of alcoholism diagnosis and treatment 
sees much to gain by prompt recognition and referral. It is easier for the clinician 
to diagnose a seemingly less complicated illness for which pharmacologic treat- 
ment can be prescribed. And it is easier for the alcoholic to deny than to recognize 
the illness. 
Faced with a disease of such ubiquity and subtlety, yet one that regularly 
accounts for large proportions of patients occupying hospital beds (l), clinical 
psychiatrists with specialized knowledge of alcoholism have historically taken the 
lead in attempting to find ways of suspecting and then diagnosing alcoholism. 
Research thrusts in this area have sought to take advantage of clinical tools, most 
notably the history, physical examination, and laboratory evaluation. Because 
physical signs generally occur late in the course of alcoholism (with the possible 
exception of trauma) most screening efforts have focused on the history and 
biochemical or hematologic signs. Similarly, most efforts at screening for alco- 
holism have focused on hospitalized or clinic populations rather than community 
samples. From a statistical point of view, this has been a serendipitous occur- 
rence . 
STATISTICAL ISSUES 
Despite the difficulties in recognizing or even suspecting the presence of alco- 
holism in any single patient, the statistical characteristics of this problem point 
toward a powerful effect once adequate screening instruments have been devel- 
oped. Recently a group of experts convened by the Director of National Institute 
of Alcohol Abuse and Alcoholism (NIAAA) to review screening methods for 
alcoholism in primary care settings heard a penetrating discussion of statistical 
issues presented by John P. Rice, Ph.D., of Washington University (21). Follow- 
ing a description of sensitivity and specificity, Dr. Rice focused on the relation- 
ship between the base rate in the population being screened with respect to the 
positive predictive value of the screening test. He pointed out that screening tests 
work best for conditions with a high rate of occurrence among the population 
being screened. We repeat an example he gave in Table 1. In this mathematical 
construct, in which sensitivity and specificity are held constant at 95%, the pos- 
itive predictive power of any screening test-the rate at which persons suffering 
from the illness will be accurately recognized by the test-varies directly with the 
base prevalence of the illness in the population. 
According to this model, a screening test with sensitivity and specificity char- 
acteristics that are significant but short of perfection can be usefully applied to 
populations whose disease prevalence rate is high. A screening examination 
whose sensitivity is in the range of 90% would be useless were it employed to 
screen for phenylketonuria, for example, in a large population. One-tenth of the 
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TABLE 1 











a Sensitivity and specificity are each held constant at 95%. 
positive cases will have been missed-a very large proportion given the number of 
live births in this nation yearly. In contrast, a screening exam with the same 
sensitivity aimed at alcoholics in a general hospital, with a prevalence rate of 
approximately 25%, will have accurately detected 22.5% of that population, all of 
whom would be suffering from alcoholism. This is a far greater proportion of 
patients than we are currently able to screen accurately. As discussed below, this 
would be especially significant in those parts of hospital populations, such as 
orthopedic units, in which patients are likely to present while still in the early 
stages of alcoholism. Using this same screening test in an outpatient setting, 
where the prevalence rate is likely to be in the range of that of the general 
population, one still gains from a reasonably sensitive and specific screening test. 
The goal of research in this area has therefore been to establish a screening test 
or tests that can be successfully applied to populations in whom there is a high rate 
of occurrence of alcoholism and in whom early diagnosis of alcoholism-that is, 
a diagnosis made prior to the onset of obvious or debilitating medical conditions- 
can be made. 
EXPERIENCE TO DATE 
In the mid-196Os, two groups began working on alcoholism screening devices 
based on the clinical history. John H. Ewing, M.D., of the University of North 
Carolina, recognizing a high prevalence rate of alcoholics on medical and surgical 
units in the general hospital, began asking a series of questions relating to alcohol 
and the four areas of symptom constellation noted above. From these efforts, he 
derived the CAGE questions presented in Table 2 (12). Their use was empirically 
derived and in Ewing’s original work, first reported in 1970, a positive response to 
any one of the CAGE questions was highly indicative of an underlying alcoholism 
diagnosis. Ewing’s work received little attention despite its having been replicated 
TABLE 2 
CAGE QUESTIONS 
1. Have you ever felt you should cut down on your drinking? 
2. Have people -nnoyed you by c&icizing your drinking? 
C 
A 
3. Have you ever felt bad or guilty about drinking? 
4. Have you ever taken a drink first thing in the morning @ye opener) 
to steady your nerves or get rid of a hangover? 
G 
E 
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in a psychiatric setting by Mayfield (15). In that study, Mayfield found that pos- 
itive responses to two of the CAGE questions served as the best cut-off score. 
Approximately 6 years ago, our group became interested in alcoholism screen- 
ing in the general hospital and began using the CAGE questions. We reported a 
high sensitivity and specificity for these questions among medical and surgical 
patients: 70 and 99%, respectively (2, 3, 4). Since that time other groups have 
likewise found Dr. Ewing’s questions to be both valid and reliable when compar- 
ing them with an assiduously done alcoholism diagnostic interview (5, 6). We 
summarize the sensitivity, specificity, and positive predictive value figures in 
Table 3. Despite their consistency, it is important to recall that these numbers may 
reflect a setting-specific phenomenon. People are more likely to speak truthfully 
in a situation in which they believe their health and well being are at stake. This 
is very much the case in a hospital setting. It may not be the case in a community 
setting. A study by Saunders and Kirshaw for example noted a much lower degree 
of accuracy for the CAGE questions (20). It is difficult to assess whether this was 
due to their study methods or to the setting, but one must continue to regard the 
question of setting as an important variable. Similarly, patient subgroups whose 
ability to give a correct history is questionable may yield lesser accuracies of 
response. For example, a study by Bemadt and colleagues of psychiatric inpa- 
tients gave validity indices significantly different than those reported in a medical 
setting: sensitivity 91%, specificity 77%, positive predictive value 45% (15). 
At about the same time as Ewing’s original derivation of the CAGE questions, 
Melvin Selzer, M.D., then at our institution began working on a set of questions 
that came to be known as the MAST (Michigan Alcohol Screening Test) (22). Like 
Ewing, he focused on a high-prevalence population: persons suspected of driving 
while under the influence of alcohol. Beginning with his efforts, the 20-question 
MAST and several of its shorter versions and offspring have become standard 
screening questionnaires in many institutions as well as a standard measure of the 
probability of alcoholism in many research reports. One version of the MAST, the 
Self-Administered Alcohol Screening Test (SAAST), developed by Robert Morse 
and colleagues at the Mayo Clinic (24), has been well validated and reliably given 
in medical settings in various parts of the United States as well as in other coun- 
tries (9, 13). 
In a recent discussion of the SAAST (21), Dr. Morse noted that discriminant 
analysis revealed that nine of the items of this 35-item questionnaire accounted for 
most of its sensitivity and specificity characteristics. Even more interestingly, two 
items of the SAAST accounted for 80% of the sensitivity and 90% of the speci- 
TABLE 3 
VALIDITY CHARACTERISTICS OF THE CAGE QUESTIONS~ IN MEDICAL SETTINGS (%) 
Positive 
Sensitivity Specificity predictive value 
Beresford ef al. (11, 13) IQ 99 97 
Bush et al. (15) 75 % 82 
a Two positive responses to any of the four questions. 
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ficity. The two questions were: “Do close relatives ever worry and complain 
about your drinking?” and “Have you ever felt the need to cut down on your 
drinking?” These questions are all but the same as two of the CAGE questions. 
It seems reasonable to conclude, therefore, that similar questions derived in dif- 
ferent settings by different groups of investigators and shown to be valid and 
reliable in screening for alcoholism probably reflect a universal phenomenon that 
is both characteristic of the disease and most easily discussed between patient and 
physician. 
Evidence such as this has led various clinical groups and expert panels to 
recommend established screening exams, such as the CAGE, the MAST, and the 
SAAST, to primary care clinicians in screening for alcoholism. The choice of 
which test to use or which several tests to use simultaneously remains for further 
investigation. The choice of test will undoubtedly be affected by the style and 
practice of one clinician vs another. For example, in a busy clinical practice with 
a premium on personal contact with patients, such as an institutional medical or 
surgical clinic, the four CAGE questions are probably of the greatest use because 
they are brief, easy to remember, and can be quickly put in one’s clinical routine. 
In a somewhat more leisurely outpatient practice, with sufficient nursing or other 
personnel to conduct a MAST interview, score a self-administered interview, or 
present a family version of either one of those interviews, the MAST or the 
SAAST may be preferable. While these instruments are available presently, and 
can be regarded as sound clinical devices, they do not answer some of the basic 
misgivings of primary clinicians when faced with the still difficult question of how 
to diagnose an alcoholic person and how to present that diagnosis. 
NEW POSSIBILITIES 
Let us consider the busy clinician, an internist for example, who faces a large 
outpatient practice and daily contact with a significant number of patients UlOth 
of whom are alcoholic. Suppose we put the CAGE questions into the internist’s 
hands and present him with a patient who answers three of the four questions 
positively. The internist tells his patient and perhaps that patient’s family that 
based on the CAGE responses the patient has a 95% chance of suffering from 
alcoholism. The patient, anxious to protect the perceived good effects of the 
drinking as well as to staving off the shame and guilt involved with loss of control 
of his alcohol use, vehemently denies any alcohol use whatsoever and states that 
he did not understand the questions properly or he would not have given those 
particular answers. The doctor’s dilemma is to provide some convincing “proof’ 
that the patient was giving true responses to the CAGE questions and that the 
patient’s problem truly is his addictive use of alcohol. The internist would be 
delighted to have on hand a variable which, independent of the patient’s historical 
responses, would point overwhelmingly toward the diagnosis of alcoholism. This 
clinical dilemma has spurred much recent research on the so-called “biologic 
markers” for alcoholism. This search has been extensively reviewed recently and 
we refer the interested reader to that discussion (27). 
From the point of view of screening, however, this same search for a biological 
parameter or parameters that might be used in tandem with a historical screening 
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mechanism would at least provide the clinician with two empirically validated 
methods of suspecting alcoholism. Some obvious candidates come to mind, such 
as the mean corpuscular volume (Z), any of a series of hepatic enzymes such as 
y-glutamyl transpeptidase (ll), uric acid (2, 7), or, most recently, desialylated 
transferrin (23). The sensitivity and specificity characteristics of elevations in 
these tests in known alcoholic and nonalcoholic patients have been studied, with 
the exception of only very early data regarding desialylated transferrin. No single 
test, to our present knowledge, appears powerful enough, which is sensitive and 
specific enough, to give it credence as a screening marker for alcoholism among 
patients walking in the door of the internist’s office. Several reasons pertain to 
this, some of which include the individual variation from one patient to the next 
on these parameters, the point at which the patient most recently began or ceased 
heavy drinking, the variation of laboratory measures compiled by one clinical 
laboratory when compared to another, and perhaps the heterogeneous nature of 
alcoholism. As screening tests aimed at large patient populations, the enzyme 
measurements present high cost to the patient or to other reimbursement parties 
that appears to outweigh any screening usefulness so far as present knowledge is 
concerned. 
Faced with this kind of dilemma, Ryback and his group at the NIAAA took a 
novel approach (18). They hypothesized that sophisticated statistical analyses, 
such as the quadratic discriminant analysis they used in their original report, when 
applied to a series of laboratory parameters, such as the entire hematologic and 
biochemical screen often ordered by practicing physicians, might yield statistical 
patterns that identified alcoholic patients. They published a report that appeared 
to substantiate their hypothesis in a study of alcoholic and nonalcoholic patients 
seen in a Veteran’s hospital. While their original enthusiasm at finding 100% 
accuracy in identifying known alcoholics may not have been completely war- 
ranted, they opened an avenue of investigation that may allow for a second 
screening mechanism, independent of the clinical history, that can be applied to 
large numbers of patients seeking assistance in health-care facilities. 
In an effort to replicate their results, our group studied 104 patients through 
both historical and laboratory data methods (2). We constructed a much simpler 
mathematical paradigm based upon a linear discriminant analysis of some 24 
hematologic and biochemical variables. Our mathematical construction came 
down to two equations presented in Fig. 1. These require addition of a series of 
products found by multiplying a constant times the patient’s specific laboratory 
values. The variables we found to be most significant were total bilirubin, lactate 
D aI-2 = -260.2 + l.G(MCV, M3) + 16.6(log BUN) - 5.3(CRE, mg/dl) 
+2.6(log TBIL), mgldl) - O.l5(SGOT, IU/L) 
-12.O(log UA, mg/dl) + 67.7(log LDH, IWL) 
D xa,c = -272.0 + 1.5(MCV) + 19.O(log BUN) - 58(CRE) 
+3.5(log TBIL) - O.l7(SGOT) - 14.O(log UA) + 70.9log (LDH) 
FIG. 1. Linear discriminant functions (LDFs). Abbreviations used: MCV, mean corpuscular vol- 
ume; BUN, blood urea nitrogen; CRE, creatinine; TBIL, total bilirubin; SGOT, serum glutamic 
oxaloacetate transaminase; UA, uric acid; LDH, lactate dehydrogenase. 
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dehydrogenase, creatinine, blood urea nitrogen, uric acid, SGOT, and the mean 
corpuscular volume. With the patient’s laboratory data values in place, each 
equation results in a numerical solution. The greater of the two numbers suggests 
either alcoholism or its absence. In our experience, this had a sensitivity of 79%, 
a specificity of 80%, and a positive predictive value of 70%. While this was far 
short of the characteristics of the CAGE questions, in our experience, it was 
nonetheless approximately as effective in identifying alcoholic patients as was a 
more time-consuming clinical history performed by a senior medical resident. We 
are presently engaged in researching this finding further in order to establish its 
validity for larger numbers of patient subjects. 
Should its clinical characteristics continue to hold up under further scrutiny and 
empirical evaluation, it might be a screening mechanism that could be easily 
translated into software procedures and used as part of the laboratory data base 
in any computerized clinical laboratory system. If that were the case, the office 
internist would have the option of asking his clinical pathology laboratory for a 
computer readout on the statistical likelihood of any specific patient suffering 
from alcoholism based on that patient’s presenting constellation of laboratory 
parameters. Much remains to be done, however, even beyond the mere validation 
of this method. Should it prove to be empirically justified, we have yet to learn 
whether a laboratory data profile has the ability to recognize alcoholic patients 
early in their drinking histories or whether the profile data could serve as a 
significant marker of both amelioration or worsening of drinking practices. The 
potential gain, a widely useable independent index of alcoholism, appears at this 
point to justify the expense and effort of further research. 
WHAT IF WE SUCCEED? 
Suppose that we had a variety of valid screening tests that could be used 
reliably throughout medical settings in this country. Suppose that we could iden- 
tify alcoholics with a frequency that approached the lifetime prevalence rate of 7% 
for the population. We would have a method of clinical identification that could 
accurately establish the high likelihood of alcoholism in some 10 to 15 million 
Americans. We would then be faced with two overwhelming clinical dilemmas. 
First, while screening examinations may provide a statistical probability of the 
presence of alcoholism, diagnosis is a more stringent exercise. It requires careful 
interviewing of both patient and family, either in a structured interview or in the 
hands of a well-experienced professional. As most seasoned clinicians know, 
dealing with alcoholic patients and their families requires clinical sophistication in 
handling what is very often an angry interchange between physician and patient or 
family and patient as well as quiet persistence in the face of an extremely difficult 
disease process. 
Part of the problem in taking care of a large number of people is the need for 
well-trained personnel. Training requires a careful understanding of and experi- 
ence with patient interviews as well as one’s own natural resistance to dealing 
with very difficult patients who both seek and reject help at the same time. While 
many specialized alcohol and substance abuse treatment clinics and facilities 
already use screening devices such as the MAST or the CAGE questions, it has 
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been our experience that very few medical or surgical clinics routinely use such 
devices. We suspect that one of the major reasons for ignoring these clinical tools 
has to do with the lack of training among medical personnel when faced with this 
dilemma. Some groups have begun to examine this area of resistance among 
health-care professionals. It is clearly one of many facets and one that will need 
to be thoroughly understood if screening procedures are to be effective in primary 
care settings. 
We are not presently aware of any specific estimates of the numbers of medical 
personnel currently capable of diagnosing alcoholism. While the diagnostic and 
statistical manual of the American Psychiatric Association (16) (DSM III-R) is in 
the hands of 10,000 or more psychiatrists in this country, we do not know how 
many of them use or regularly consult the DSM III-R around alcohol dependence. 
Similarly, while the National Council on Alcoholism jointly published criteria for 
alcoholism in both medical and psychiatric journals many years ago (16) there are 
no data of which we are aware outlining the extent to which those diagnostic 
categories are in fact used. There is clearly a major need for education of medical 
personnel in this area. 
What can be said of diagnosis likewise applies to treatment. The National Drug 
and Alcoholism Treatment Utilization Survey published in 1983 provides some 
numbers in estimating treatment capacity for alcoholism and other forms of drug 
dependency (17). This report stated that the capacity in the nation for treating 
alcoholism consisted of the ability to treat approximately 345,000 patients. While 
undoubtedly this capacity has increased over the past 5 years, if that number had 
tripled we would still have only a treatment capacity equal to approximately l/10 
of the lifetime prevalence of alcoholism. Further, it is worth noting that approx- 
imately two-thirds of the funding for alcoholism treatment services, according to 
the same survey, came from public sources. Only 26% was financed by the private 
health insurance industry. This is despite the fact that the overwhelming majority 
of Americans suffering from alcoholism continue to be employed, live with their 
families, and are generally ineligible for most forms of public financial assistance. 
It seems clear to us that as further research on screening mechanisms unfold, as 
the incidence of recognition of alcoholics increases with our increased ability to 
screen for this disease, it will serve to highlight the training and treatment needs 
of the health professions in addressing this national problem. We believe that the 
political ramifications of this will be unavoidable and the education of our public 
officials and populus at large will be most important in the coming years. 
CONCLUSION 
Research on screening examinations for alcoholism has continued for the past 
20 years. We now have valid and reliable screening interviews and questionnaires 
that are brief and clinically accurate. Examples such as the CAGE questions, the 
MAST, and the SAAST are currently available to health-care and other profes- 
sionals. They are generally useful for a wide range of patients although research 
needs to be done with respect to specific subpopulations yielding instruments 
tailored to adolescents, to women, and to the elderly. Research is being done with 
respect to biological markers that may serve as possible screening mechanisms 
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for alcohol use. Efforts in this area have been directed at single tests, for example 
y-glutamyl-transpeptidase, and at batteries of laboratory tests, such as the labo- 
ratory data profile. While much work remains to be done in validating these tests, 
they offer the possibility of wide use at low cost. The increasing use of screening 
tests has increased our accessibility to an underserved patient population. This in 
turn has pointed out the need for more education of medical and other health- 
treatment personnel as well as clear questioning of our current national capacities 
for treating alcoholic and other drug-dependent persons. As research in screening 
examinations moves forward, these other areas will necessarily be brought to the 
attention of the public and government. 
REFERENCES 
1. Beresford, T. P. Alcoholism consultation and general hospital psychiatry. Gen. Hosp. Psychiatry 
2, 293-300 (1979). 
2. Beresford, T. P., Low, D., Hall, R. C. W., Adduci, R., and Goggans, F. A computerized bio- 
chemical profile for detection of alcoholism. Psychosomntics 23, 713-720 (1982). 
3. Beresford, T. P., Low, D., Adduci, R., and Goggans, F. Alcoholism assessment on an orthopedic 
surgery service. J. Bone Joint Surg. 64A, 730-733 (1982). 
4. Beresford, T. P. Screening for alcohol abuse using the CAGE questionnaire (Letter). Amer. J. 
Med. 83, 805 (1987). 
5. Bernadt, M. W., Taylor, C., Mumford, J., Smith, B., and Murray, R. M. Comparison of ques- 
tionnaire and laboratory tests in the detection of excessive drinking and alcoholism. Lance? 1, 
325-328 (1982). 
6. Bush, B., Shaw, S., Cleary, P., Delbanco, T. L., and Aronson, M. D. Screening for alcohol abuse 
using the CAGE questionnaire. Amer. J. Med. 82, 231-235 (1987). 
7. Campion, E. W., Glynn, R. J., and DeLabry, L. 0. Asymptomatic hyperuricemia. Amer. J. Med. 
82, 421-426 (1987). 
8. Criqui, M. H. Alcohol consumption, blood pressure, lipids, and cardiovascular mortality. Alcohol 
C&z. Exp. Res. 10, 564 (1986). 
9. de la Fuente, J. R., Gutierrez, L. M., Rivero, F., et al. Early detection of alcoholism in a hospital 
population. Rev. Invest. Clin. 34, l-6 (1982). 
10. “Diagnostic and Statistical Manual of Mental Disorders” (DSM III-R), 3rd ed., revised. American 
Psychiatric Association, 1987. 
11. Devjun, M. S., Dunbar, J. A., Hagart, J., Martin, B. T., and Ogston, S. A. Effects of acute and 
varying amounts of alcohol consumption on alkaline phosphatase, aspartate transaminase, and 
y-glutamyltransferase. Alcohol Clin. Exp. Res. 9, 235-237 (1985). 
12. Ewing, J. A. Detecting alcoholism, the CAGE questionnaire. JAMA 252, 1905-1907 (1984). 
13. Hurt, R. D., Morse, R. M., and Swenson, W. M. Diagnosis of alcoholism without self- 
administered alcohol screening test. Mayo Chit. Proc. 55, 365-380 (1980). 
14. MacMahon, S. Alcohol consumption and hypertension. Hypertension 9, 111-121 (1987). 
15. Maylield, D., McLeod, G., and Hall, P. The CAGE questionnaire: Validation of a new alcoholism 
screening instrument. Amer. J. Psych&. 131, 1121-1123 (1974). 
16. National Council on Alcoholism. Criteria for the diagnosis of alcoholism. Amer. J. Psychiat. 129, 
127-135; Ann. Intern. Med. 77, 249-258 (1972). 
17. “National Drug and Alcoholism Treatment Utilization Survey,” U.S. Department of Health and 
Human Services, September 1983. 
18. Ryback, R. S., Eckardt, M. J., and Pautler, C. P. Biochemical and hematological correlates of 
alcoholism. Res. Commun. Gem. Pathol. Pharmacol. 27, 533-550 (1980). 
19. Saunders, J. B., Davis, M., and Williams, R. Do women develop alcoholic liver disease more 
readily than men? Brit. Med. J. 282, 1140-3 (1981). 
20. Saunders, W. M., and Kershaw, P. W. Screening tests for alcoholism, findings from a community 
study. Brit. J. Addict. 75, 37-41 (1980). 
21. “Screening for Alcoholism in Primary Care Settings,” report of a workshop held in Bethesda, 
CLINICAL APPLICATIONS 663 
Maryland, May 27, 1987. US. Department of Health and Human Services, National Institute 
on Alcohol Abuse and Alcoholism, Alcohol, Drug Abuse, and Mental Health Administration, 
Rockville, MD 20857. 
22. Seltzer, M. L. The Michigan alcoholism screening test: the quest for a new diagnostic instrument. 
Amer. J. Psychiut. 127, 1653-1658 (1971). 
23. Storey, E. L. Desialylated transferrin as a serological marker of chronic excessive alcohol inges- 
tion. Lancer 1, 1291-1294 (1987). 
24. Swenson, W. M., and Morse, R. M. The use of a self-administered alcohol screening test 
(SAAST) in a medical center. Mayo C/in. Proc. 50, 204-208 (1975). 
25. VailIant, G. “Natural History of Alcoholism,” p. 316. Harvard Univ. Press, Cambridge, 1983. 
26. Vaillant, G. “Natural History of Alcoholism,” pp. 107-180. Harvard Univ. Press, Cambridge, 
1983. 
27. Watson, R. R., Mohs, M. E., Eskelson, C., et al. Identification of alcohol abuse and alcoholism 
with biological parameters. Alcohol Clin. Exp. Res. 10, 364-385 (1986). 
28. West, J. R. Fetal alcohol-induced brain damage and the problem of determining temporal vulner- 
ability: A review. Alcohol Drug Res. 7, 423&l (1987). 
